VIDEO: 2018 – A Year in Review

21/12/2018

We would like to wish our generous supporters a safe and happy Christmas and New Year!

This year, your belief in our life-saving researcher has helped us:

  • Improve the diagnosis rate of a potentially deadly heart condition by up to 20 per cent.
  • Discover a potential new pathway for cancer therapies.
  • Boost the human body’s fight against melanoma by uncovering a new pathway in the body.
  • Gain new insight into the never-ending arms race between viruses and their hosts.
  • Uncover a brand new virus underpinning kidney disease.
  • Progress towards the development of a more effective vaccine against tuberculosis.
  • Uncover the causes and mechanisms of Alzheimer’s disease.
  • Discover a cure for a sub-set of one of the most common genetic blood diseases in the world, Beta-thalassemia.
  • Develop a novel drug which is being touted as a major step forward in the battle against obesity.
  • Create a more realistic model of primary liver cancer.
  • Determine how to develop safer blood-clotting drugs.

Hear from our scientists themselves about how your support has helped improve human health!

Check out our media centre for further information on these breakthroughs and discoveries.

Latest News

Prof John Rasko AO and collaborators publish world-first clinical stem cell study

Professor John Rasko AO has led a world-first clinical trial into engineered stem cell treatment use, treating 15 patients with steroid resistant acute graft-versus-host disease.

Enzyme insight could lead to new diabetes treatment

Centenary Institute research has discovered that the lack of an enzyme in the liver called sphingosine kinase 2 results in pronounced insulin resistance and glucose intolerance, both symptoms of early stage type 2 diabetes.

Reducing cirrhosis threat for high-risk drinkers

Research led by the Centenary Institute has shown that a healthy weight and coffee consumption may help lower the risk of high-risk drinkers developing alcohol-induced cirrhosis.

 

News Topics

ALL NEWS

 


Sign up for our latest News